Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Drug Drug Interaction (DDI)”

155 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 155 results

Early research (Phase 1)Not Yet RecruitingNCT07372625
What this trial is testing

Investigate the Effects of Multiple Doses of Rezatapopt on the Pharmacokinetics of Metformin, Rosuvastatin, Repaglinide, and Midazolam in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation.

Who this might be right for
TP53 Y220C MutationAdvanced Solid Tumors
PMV Pharmaceuticals, Inc 14
Early research (Phase 1)Study completedNCT04134715
What this trial is testing

A Drug Drug Interaction Study Between PF-06826647 And Oral Contraceptive Steroids In Healthy Female Participants

Who this might be right for
Healthy
Pfizer 15
Testing effectiveness (Phase 2)Temporarily pausedNCT03756922
What this trial is testing

A DDI Study of FDL169 and FDL176 in Healthy Subjects

Who this might be right for
Cystic Fibrosis
Flatley Discovery Lab LLC 78
Testing effectiveness (Phase 2)Study completedNCT00000838
What this trial is testing

Antiviral Activity of and Resistance to Lamivudine in Combination With Zidovudine, Stavudine, or Didanosine

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 256
Early research (Phase 1)Study completedNCT04843449
What this trial is testing

Study to Evaluate the Effects of Itraconazole and Rifampin on the Pharmacokinetics of ASC40 in Healthy Subjects

Who this might be right for
Healthy
Ascletis Pharmaceuticals Co., Ltd. 24
Early research (Phase 1)Active Not RecruitingNCT06632990
What this trial is testing

A Study Evaluating the Potential of BMS-984923 to Alter the Systemic Exposure of Three Orally Administered Probe Substrates

Who this might be right for
Drug Drug Interaction (DDI)
Allyx Therapeutics 36
Early research (Phase 1)Study completedNCT04171739
What this trial is testing

Drug-drug Interaction (DDI) Study to Assess Effect of Itraconazole and Rifampicin Upon Olorofim

Who this might be right for
Healthy
F2G Biotech GmbH 24
Early research (Phase 1)Study completedNCT00860275
What this trial is testing

Drug-Drug Interaction (DDI) w/Ketoconazole or Fluconazole

Who this might be right for
Alzheimer Disease
Bristol-Myers Squibb 30
Early research (Phase 1)Study completedNCT01663961
What this trial is testing

Evaluate the Effect of a Single Dose of Digoxin on the Actions in the Bodies of Healthy Subjects After Having Taken Several Doses of YM178

Who this might be right for
Healthy
Astellas Pharma Europe B.V. 25
Early research (Phase 1)Study completedNCT05117554
What this trial is testing

Study to Investigate the Safety, Tolerability, and Pharmacokinetic Profile With Oral AB521 in Healthy Volunteers

Who this might be right for
Healthy Participants
Arcus Biosciences, Inc. 70
Testing effectiveness (Phase 2)Study completedNCT00001114
What this trial is testing

The Safety and Effectiveness of Interferon Alfa-2B Plus Didanosine in Patients With Kaposi's Sarcoma

Who this might be right for
Sarcoma, KaposiHIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 90
Early research (Phase 1)Not Yet RecruitingNCT07367971
What this trial is testing

Drug-Drug Interaction Study of ABP-671 in Gout Patients

Who this might be right for
Gout ChronicGoutDDI (Drug-Drug Interaction)
Atom Therapeutics Co., Ltd 20
Early research (Phase 1)Study completedNCT02626234
What this trial is testing

A Drug-drug Interaction (DDI) Study to Assess the Effect of INC280 on the Pharmacokinetics of Digoxin and Rosuvastatin in Patients With cMET-dysregulated Advanced Solid Tumors

Who this might be right for
cMET-dysregulated Advanced Solid Tumors
Novartis Pharmaceuticals 32
Early research (Phase 1)Study completedNCT02846142
What this trial is testing

Study to Assess the Safety, Tolerability, PK, ECG Effects, Food Effect, and Drug-drug Interaction (DDI) of Hormonal Contraceptives of PTI-428 in Healthy Female Volunteers

Who this might be right for
Healthy Volunteer
Proteostasis Therapeutics, Inc. 94
Early research (Phase 1)Study completedNCT00000954
What this trial is testing

Chemotherapy Plus ddI or ddC in the Treatment of AIDS-Related Kaposi's Sarcoma

Who this might be right for
Sarcoma, KaposiHIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 72
Early research (Phase 1)Study completedNCT06491550
What this trial is testing

Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of AZD4144 as Well as the Impact of AZD4144 on the Pharmacokinetics of Rosuvastatin and Furosemide in Healthy Participants

Who this might be right for
Healthy Participants
AstraZeneca 91
Early research (Phase 1)Study completedNCT02480881
What this trial is testing

A Drug-drug Interaction Study Between BMS-663068 and Oral Contraceptives in Healthy Female Volunteers (DDI)

Who this might be right for
Infection, Human Immunodeficiency Virus
ViiV Healthcare 26
Early research (Phase 1)Study completedNCT02127034
What this trial is testing

Study to Evaluate the Effect of Solifenacin and Mirabegron on the Digoxin Concentrations in Blood in Healthy Subjects

Who this might be right for
Healthy SubjectsPharmacokineticsDrug-Drug Interaction (DDI)
Astellas Pharma Europe B.V. 26
Early research (Phase 1)Looking for participantsNCT06733675
What this trial is testing

Safety and PK of Ceftibuten-ledaborbactam Etzadroxil Fixed-dose Combination

Who this might be right for
Healthy VolunteerPharmacokineticsSafety+2 more
Basilea Pharmaceutica 46
Early research (Phase 1)Study completedNCT01937260
What this trial is testing

Brodalumab Drug-Drug Interaction (DDI) and Intensive Pharmacodynamic (PK) Study in Psoriasis Subjects

Who this might be right for
Psoriasis
Bausch Health Americas, Inc. 31
Load More Results